Adipose tissue at the crossroads in the development of the metabolic syndrome, inflammation and atherosclerosis;Tecido adiposo na encruzilhada no desenvolvimento da síndrome metabólica, inflamação e aterosclerose

Arquivos Brasileiros de Endocrinologia e Metabologia

Volumn 53, Issue 2, 2009, Pages 145-150

  Wajchenberg, Bernardo Léo ^a   Nery, Marcia ^a   Cunha, Maria Rosaria ^a   da Silva, Maria Elizabeth Rossi ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Atherosclerosis; Low grade inflammation; Metabolic syndrome; Obesity; Visceral and subcutaneous adipose tissue

Indexed keywords

EID: 67649406270     PISSN: 00042730     EISSN: 16779487     Source Type: Journal    
DOI: 10.1590/S0004-27302009000200005     Document Type: Review

References (27)

1. Reaven GM. Banting Lecture 1988. Role of insulin resistance in human disease. Diabetes. 1988;37(12):1595-607.
2. Yudkin JS. Insulin resistance and and the metabolic syndrome - or the pitfalls of epidemiology. Diabetologia. 2007;50(8):1576-86.
3. Gale EA. The myth of the metabolic syndrome. Diabetologia. 2005;48(9):1679-83.
4. Pinkney J, Coppack SW, Yudkin JS. Endothelial dysfunction: cause of the insulin resistance syndrome? Diabetes. 1997;46 Suppl 2:S9-S13
5. Yudkin JS, Stehouwer CDA, Emeis JJ, Coppack SW. C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role of cytokines originating from adipose tissue? Arterioscler Thromb Vasc Biol. 1999;19(4):972-8.
6. Wajchenberg BL, Giannella-Neto D, Silva MER, Santos RF. Depotspecific hormonal characteristics of sub-cutaneous and visceral adipose tissue and their relation to the metabolic syndrome. Horm Metab Res. 2002;34(11-12):616-21.
7. Karelis AD, St-Pierre DH, Conus F, Rabasa-Lhoret R, Poehlman ET. Metabolic and body composition factors in subgroups of obesity: what do we know? J Clin Endocrinol Metab. 2004;89(6):2569-75.
8. Stefan N, Kantartzis K, Schick F, Thamer K, Rittig K, Balletshofer B, et al. Identification and characterization of Metabolically benign obesity in humans. Arch Intern Med. 2008;168(15):1609-16.
9. Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science. 1993;259(5091):87-91.
10. Scherer P. Adipose tissue: from lipid storage compartment to endocrine organ. Diabetes. 2006;55(6):1537-45.
11. Scherer PE. Adipose tissue: from lipid storage compartment to endocrine organ. Diabetes. 2006;55:1537-45
12. Wajchenberg BL. Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocr Rev. 2000;21(6):697-738.
13. Yang X, Smith U. Adipose tissue distribution and risk of metabolic disease: does thiazolidinedione-induced adipose tissue redistribution provide a clue to the answer? Diabetologia. 2007;50(6):1127-39.
14. Kamei N, Tobe K, Suzuki R, Ohsugi M, Watanabe T, Kubota N, et al. Overexpression of monocyte chemoattractant protein-1 in adipose tissues causes macrophage recruitment and insulin resistance. J Biol Chem. 2006;281(36):26602-14.
15. Berg AH, Scherer PE. Adipose tissue, inflammation, and cardiovascular disease. Circulation Res. 2005;96(9):939-49.
16. Bloomgarden ZT. Inflammation, atherosclerosis and aspects of insulin action. Diabetes Care. 2005;28(9):2312-9.
17. Davi G, Guagnano MT, Ciabattoni G, Basili S, Falco A, Marinopiccoli M, et al. Platelet activation in obese women: role of inflammation and oxidant stress. JAMA. 2002;288(16):2008-14.
18. Sobel BE. Increased plasminogen activator inhibitor-1 and vasculopathy. A reconcilable paradox. Circulation. 1999;99(19): 2496-8.
19. Wellen KE, Hotamisligil GS. Inflammation, stress and diabetes. J Cin Invest. 2005;115:1111-9.
20. Kusminski CM, da Silva NF, Fowler AE, Creely JS, Harte AL, Baker AR, et al. The effects of adiposity, diabetic status and depot-specificity on the activation of NF-κβ on JNK in human abdominal adipose tissue. Diabetologia. 2007;50 Suppl 1: Abstract 0153, S69.
21. Wajchenberg BL, Nery M. Adipose tissue and inflammation. Obesity and Metabolism. 2008;4:96-8.
22. Nicoletti G, Giugliano MT, Pontillo A, Cioffi M, D'Andrea F, Giugliano D. Esposito K. Effect of a multidisciplinary program of weight reduction on endothelial function in obese women. J Endocrinol Invest. 2003;26(3):RC5-8.
23. Heilbroon LK, Noakes M, Clifton PM. Energy restriction and weight loss on very-low-fat diets reduce C-reactive protein concentrations in obese, healthy women. Arterioscl Thromb Vasc Biol. 2001;21(6):968-70.
24. Klein S, Fontana L, Young VL, Coggan AR, Kilo C, Patterson BW, Mohammed BS. Absence of effect of liposuction on insulin action and risk factors for coronary heart disease. N Engl J Med. 2004;350(25):2549-57.
25. Lee CH, Olson P, Evans RM. Mini-review: lipid metabolism, metabolic diseases, and peroxisome proliferators-activated receptors. Endocrinology. 2003;144(6):2201-7.
26. th Annual Meeting, 2007 June 2-5; OR 28, p. 111.
27. Schaffler A, Muller-Ladner U, Scholmerich J, Bucher C. Role of adipose tissue as an inflammatory organ in human disease. Endocr Rev. 2006;27(5):449-67.